ATE397591T1 - Verfahren zu herstellung von hiv-protease inhibitoren und zwischenprodukten für ihrer herstellungen - Google Patents

Verfahren zu herstellung von hiv-protease inhibitoren und zwischenprodukten für ihrer herstellungen

Info

Publication number
ATE397591T1
ATE397591T1 AT97940770T AT97940770T ATE397591T1 AT E397591 T1 ATE397591 T1 AT E397591T1 AT 97940770 T AT97940770 T AT 97940770T AT 97940770 T AT97940770 T AT 97940770T AT E397591 T1 ATE397591 T1 AT E397591T1
Authority
AT
Austria
Prior art keywords
production
protease inhibitors
intermediate products
hiv protease
producing hiv
Prior art date
Application number
AT97940770T
Other languages
English (en)
Inventor
Srinivasan Babu
Bennett Borer
Travis Remarchuk
Robert Szendroi
Kathleen Whitten
Juliette Busse
Kim ALBIZATI
Original Assignee
Agouron Pharma
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma, Japan Tobacco Inc filed Critical Agouron Pharma
Application granted granted Critical
Publication of ATE397591T1 publication Critical patent/ATE397591T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97940770T 1996-09-05 1997-09-04 Verfahren zu herstellung von hiv-protease inhibitoren und zwischenprodukten für ihrer herstellungen ATE397591T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/708,607 US5705647A (en) 1996-09-05 1996-09-05 Intermediates for making HIV-protease inhibitors

Publications (1)

Publication Number Publication Date
ATE397591T1 true ATE397591T1 (de) 2008-06-15

Family

ID=24846475

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97940770T ATE397591T1 (de) 1996-09-05 1997-09-04 Verfahren zu herstellung von hiv-protease inhibitoren und zwischenprodukten für ihrer herstellungen

Country Status (16)

Country Link
US (1) US5705647A (de)
EP (1) EP0931071B1 (de)
JP (2) JP2001501183A (de)
AR (1) AR009532A1 (de)
AT (1) ATE397591T1 (de)
AU (1) AU4247097A (de)
CA (1) CA2264725A1 (de)
CO (1) CO4900044A1 (de)
DE (1) DE69738751D1 (de)
ES (1) ES2306461T3 (de)
ID (1) ID17012A (de)
IN (1) IN183739B (de)
MY (1) MY132553A (de)
UY (1) UY24697A1 (de)
WO (1) WO1998009952A1 (de)
ZA (1) ZA977868B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962725A (en) 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US5925759A (en) 1996-09-05 1999-07-20 Agouron Pharmaceuticals, Inc. Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
US6001851A (en) * 1997-03-13 1999-12-14 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US6130348A (en) * 1997-04-10 2000-10-10 Hoffmann-La Roche Inc. Process for a phenylthiobutyl-isoquinoline and intermediates therefor
CA2286013C (en) * 1997-04-10 2003-07-15 F. Hoffmann-La Roche Ag Process for making a butylthio-isoquinoline and intermediates therefor
US6084107A (en) * 1997-09-05 2000-07-04 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
WO1999048371A1 (en) * 1998-03-27 1999-09-30 The Regents Of The University Of California Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors
US20050049242A1 (en) * 2000-12-21 2005-03-03 W. Edward Robinson Novel HIV integrase inhibitors and HIV therapy based on drug combinations including integrase inhibitors
US6943001B2 (en) * 2001-08-03 2005-09-13 Diversa Corporation Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
CA2456229A1 (en) * 2001-08-03 2003-02-13 Diversa Corporation Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
SG145574A1 (en) * 2003-05-08 2008-09-29 Pfizer Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
KR101449353B1 (ko) * 2010-10-22 2014-10-08 미쓰이 가가쿠 가부시키가이샤 환상 황산 에스테르 화합물, 그것을 함유하는 비수 전해액, 및 리튬이차전지

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5142056A (en) * 1989-05-23 1992-08-25 Abbott Laboratories Retroviral protease inhibiting compounds
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
IL91307A0 (en) * 1988-08-24 1990-03-19 Merck & Co Inc Hiv protease inhibitors and pharmaceutical compositions for the treatment of aids containing them
EP0361341A3 (de) * 1988-09-28 1991-07-03 Miles Inc. Therapeutika für AIDS auf der Basis von HIV-Protease-Inhibitoren
US5063208A (en) * 1989-07-26 1991-11-05 Abbott Laboratories Peptidyl aminodiol renin inhibitors
WO1991008221A1 (en) * 1989-12-04 1991-06-13 Wisconsin Alumni Research Foundation Peptide inhibitors of hiv protease
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
GB8927915D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Novel alcohols
CA2032259A1 (en) * 1989-12-18 1991-06-19 Wayne J. Thompson Hiv protease inhibitors useful for the treatment of aids
CA2056911C (en) * 1990-12-11 1998-09-22 Yuuichi Nagano Hiv protease inhibitors
CS35692A3 (en) * 1991-02-08 1992-09-16 Sankyo Co Novel beta-amino-alpha-hydroxycarboxylic acids and pharmaceuticalcompositions comprising thereof
US5235039A (en) * 1991-06-10 1993-08-10 Eli Lilly And Company Substrates for hiv protease
CN1071930A (zh) * 1991-07-10 1993-05-12 伊莱利利公司 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂
DE4126482A1 (de) * 1991-08-10 1993-02-11 Bayer Ag (alpha)-trifluormethyl-substituierte, gesaettigt-bicyclische amine und verfahren zu deren herstellung
US5516784A (en) * 1991-08-13 1996-05-14 Schering Corporation Anti-HIV (AIDS) agents
EP0534511A1 (de) * 1991-08-16 1993-03-31 Merck & Co. Inc. HIV-Protease-Hemmer zur Behandlung von AIDS
US5256783A (en) * 1991-09-18 1993-10-26 Hoffmann-La Roche Inc. Method for producing 2-isoquinoline compounds
WO1993008184A1 (en) * 1991-10-23 1993-04-29 Merck & Co., Inc. Hiv protease inhibitors
AU3278293A (en) * 1991-12-20 1993-07-28 Syntex (U.S.A.) Inc. Cyclic amides of 3-amino-2-hydroxy-carboxylic acids as hiv-protease inhibitors
DE69300043T2 (de) * 1992-03-13 1995-05-24 Bio Mega Boehringer Ingelheim Substituierte Pipecoline-Säurederivate als HIV-Protease-Hemmer.
EP1447398A1 (de) * 1992-05-21 2004-08-18 Monsanto Company Inhibitoren von Retroviraler Protease
PT810209E (pt) * 1992-08-25 2002-09-30 Searle & Co Hidroxietilamino-sulfonamidas de alfa- e beta-aminoacidos uteis como inibidores de protease retroviral
ES2103488T3 (es) * 1992-08-25 1997-09-16 Searle & Co N-(alcanoilamino-2-hidroxipropil)sulfonamidas utiles como inhibidores de proteasas retrovirales.
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5434265A (en) * 1992-12-22 1995-07-18 Eli Lilly And Company Inhibitors of HIV protease
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US5527829A (en) * 1994-05-23 1996-06-18 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
WO1998009952A1 (en) 1998-03-12
ES2306461T3 (es) 2008-11-01
JP2001501183A (ja) 2001-01-30
AU4247097A (en) 1998-03-26
JP2009040788A (ja) 2009-02-26
MY132553A (en) 2007-10-31
DE69738751D1 (de) 2008-07-17
UY24697A1 (es) 1997-10-21
EP0931071A1 (de) 1999-07-28
ID17012A (id) 1997-11-27
IN183739B (de) 2000-04-01
AR009532A1 (es) 2000-04-26
CA2264725A1 (en) 1998-03-12
CO4900044A1 (es) 2000-03-27
US5705647A (en) 1998-01-06
EP0931071B1 (de) 2008-06-04
ZA977868B (en) 1998-03-30

Similar Documents

Publication Publication Date Title
DE69512530D1 (de) Anzeigeartikel und verfahren zu ihrer herstellung
DE59602652D1 (de) Zahnbürste und verfahren zu ihrer herstellung
DE69624457D1 (de) ArOMATIsIERTE PRODUKTE UND VERFAHREN ZU IHRER HERSTELLUNG
DE69628283D1 (de) Retroreflektierende anzeige-artikel, kit zu ihrer herstellung und verfahren zur herstellung von anzeige-artikeln
DE69814891D1 (de) Zusammengesetzte umkehrosmosemembran und verfahren zu ihrer herstellung
DE59303039D1 (de) Mikroorganismen für die produktion von tryptophan und verfahren zu ihrer herstellung
DE69327327D1 (de) Vernetzte zellstoffprodukte und verfahren zu ihrer herstellung
ATE206131T1 (de) Phosphonomonoesternnukleinsäuren, verfahren zu ihrer herstellung und ihre verwendung
DE69530976D1 (de) Schleifgegenstände und verfahren zu ihrer herstellung
DE69721399D1 (de) Verfahren für die herstellung von zementplatten
DE69825960D1 (de) In 2-position substituierte 7-haloindene und verfahren zu ihrer herstellung
DE69710426D1 (de) Verpackung für Inklusionsprodukt und Verfahren zu seiner Herstellung
DE69620405D1 (de) Verbesserte polyarylenetherzusammensetzungen und verfahren zu ihrer herstellung
DE69825253D1 (de) Verfahren für die herstellung von 1,1,1,3,3-pentafluorpropen und 2-chlor-pentafluorpropen
DE69425143D1 (de) Verbesserte expandierte ptfe-faser und verfahren zu ihrer herstellung
DE69002661D1 (de) Emaillierfaehige stahlbleche und verfahren zu ihrer herstellung.
DE69412618D1 (de) Zerfaserte flaumpulpe, und verfahren zu ihrer herstellung
DE69302810D1 (de) Verbundwerkstoffe und verfahren zu ihrer herstellung
ATE397591T1 (de) Verfahren zu herstellung von hiv-protease inhibitoren und zwischenprodukten für ihrer herstellungen
DE59401246D1 (de) Ringförmiges Maschinenteil und Verfahren zu dessen Herstellung
DE69716420D1 (de) Bitumenzusammensetzungen und verfahren zu ihrer herstellung
DE68905247D1 (de) Mineralfaser-akustikplatte und verfahren zu ihrer herstellung.
DE69433296D1 (de) Eisen-lactoferrin kombination und verfahren zu ihrer herstellung
DE69009532D1 (de) Umwickelelement für ringförmigen Artikel und Verfahren zu dessen Herstellung.
DE69510774D1 (de) Katschukzusammensetzung und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties